8 am – 8:10 am
Official opening
Associate Professor & Head of the Program of Mastology - Federal University of Goias Mastologist at Breast and Gynecology Service - Araujo Jorge Hospital - Goias Anticancer Association
8:10 am – 8:50 am
General session 1
Coordinator:
Discussants:
Full Professor UFPR. Ex.Senior Research EORTC. Head of the Mastology Service and Discipline HC-UFPR.
8:10 am – 8:20 am
Effect of vitamin D supplementation on the pathological complete response to neoadjuvant chemotherapy in women with breast cancer: a randomized clinical trial
8:20 am – 8:30 am
Breast cancer screening based on physical examination of the breast performed by community health workers: Itaberaí Project
8:30 am – 8:40 am
Machine learning model to predict resistance to neoadjuvant chemotherapy in breast cancer
8:40 am – 8:50 am
Discussion
8:55 am – 9:25 am
Gold Satellite Symposium – MSD – How immunotherapy redefines the treatment of high-risk triple negative breast cancer
Mastologist at the General Hospital of Fortaleza. Member of SBM / ASCO / ASBrS. President of the commission specialized in Mastology. Co-founder of the Breast Cancer Brazil initiative.
9:30 am – 9:50 am
Silver Satellite Symposium – DAIICHI SANKYO – The journey of the patient with breast cancer – care with a multidisciplinary team
Speaker:
Oncologist at D'Or Oncology and the National Cancer Institute - INCA
Chairwoman:
9:50 am – 10:30 am
Coffee Break
10:30 am – 11:10 am
General session 2
Coordinator:
Full member of the Brazilian Society of Mastology (SBM). President of the Department of Oncoplasty and Breast Reconstruction at SBM. Master and PhD in Health Sciences from UnB. Mastologist at Hospital Israelita Albert Einstein in Goiânia. Organizer of the Theoretical-Practical Continuing Education program in Oncoplasty and Breast Reconstruction at SBM, at Hospital Araújo Jorge, in Goiânia.
Discussants:
Professor of Surgery. Division of Surgical Oncology. Director, Breast Surgery Oncology Fellowship.
Mastologist at Hospital da Mulher - UNICAMP and Clínica FEMME PhD from UNICAMP.
10:30 am – 10:40 am
Randomized clinical trial: breast cancer screening based on physical examination performed by community health workers
10:40 am – 10:50 am
Vacuum-Assisted Excision (VAE): a single-step approach to the diagnosis and treatment of Early Breast Cancers (EBC) – initial report
10:50 am – 11 am
External prostheses after mastectomy: adhesion, manufacture and selection of a low-cost functional model to be performed in developing countries
11 am – 11:10 am
Discussion
11:15 am – 11:35 am
Silver Satellite Symposium – LILLY – Cyclin inhibitors: do the differences make a difference in clinical practice?
11:40 pm – 11:45 am
BBCS 2024 Awards
Coordinators:
Associate Professor & Head of the Program of Mastology - Federal University of Goias Mastologist at Breast and Gynecology Service - Araujo Jorge Hospital - Goias Anticancer Association
Mastologist, Master's and PhD from the Federal University of Goiás. Professor at the Federal University of Goiás.
11:45 pm – 12:05 pm
Mini Conference: How should molecular classification be approached in a dynamic scenario of changes in gene expression during the course of the disease?
Chairman:
Clinical Oncologist at Hospital Alemão Oswaldo Cruz, in São Paulo. Master in Molecular Oncology. President of the FEMAMA Scientific Council. Coordinator of the SBOC palliative care committee.
Speaker:
Professor in the Department of Genetics and a faculty member at the University of North Carolina (UNC-Chapel Hill) since 2000.
Member of the American Association for Cancer Research, American Society of Clinical Oncology and ALLIANCE Breast Committee and the Translational Breast Cancer Research Consortium.
During his career, he received the following awards:
2 pm – 2:40 pm
General session 3
Coordinator:
Mastologist. Doctor at the Oncoclínicas SP Group. Medical Leader at Hospital da Mulher SP. Deputy Treasurer of the Brazilian Society of Mastology.
Discussants:
Dr. Tadahiko Shien MD, Ph.D. (Ph.D.-surgical medicine) is a director of the Breast and Endocrine Surgery Department at Okayama University Hospital and the JCOG Breast Cancer Study Group chair. He is a surgical oncologist researching the treatment strategy for de-novo stage IV breast cancer (PI of JCOG1017 study) and Oligometastasis. His clinical and research interests primarily focus on breast surgical oncology, tumor biology, clinical trials, and translational research. He is a member of the American Society of Clinical Oncology (ASCO), Japan Surgical Society (JSS), Japan Society of Clinical Oncology (JSCO), Japan Breast Cancer Society (JBCS), Japan Society of Medical Oncology (JSMO), International Society of Surgery (ISS), Japan Oncoplastic Breast Surgery Society (JOBSS), Japan Association of Endocrine Surgery (JAES), and Breast Surgery International (BSI). His board-certified specialties are JSS, JSCO, and JAES, and the Board of JBCS and JAES. He is an associate editor of BMC Women’s Health, Frontier in Oncology, and Oncology letters.
Prof. Adjunto II do Departamento de Medicina da Disciplina Oncologia da Universidade Federal do Maranhão; Mastologista com foco em Oncoplastia e Cirurgia Oncológica; Coordenador do serviço de Mastologia do Hospital Oncológico do Maranhão; Coordenador do Serviço de Mastologia do Hospital São Domingos _Rede Dasa.
2 pm – 2:10 pm
Is it possible to omit axillary surgery after neoadjuvant therapy for breast cancer? Preliminary outcomes in patients who underwent neoadjuvant treatment in the ongoing VENUS trial – a randomized controlled clinical trial
2:10 pm – 2:20 pm
Disparity in access to anti-her-2 therapies in neoadjuvant chemotherapy: a prognostic analysis based on real world data between public and private systems in Brazil
2:20 pm – 2:30 pm
The diffusion sequence by magnetic resonance in the diagnosis of breast cancer: an analysis of accuracy
2:30 pm – 2:40 pm
Discussion
2:45 pm – 3:25 pm
Gold Satellite Symposium – NOVARTIS – A2A: Treatment of HR+/HER2- luminal breast cancer
Speaker:
Clinical Oncologist - Leader of Breast Oncology at Hospital Nora Teixeira da Santa Casa de Porto Alegre. PhD in Medical Sciences from UFRGS.
Associate Professor & Head of the Program of Mastology - Federal University of Goias Mastologist at Breast and Gynecology Service - Araujo Jorge Hospital - Goias Anticancer Association
3:30 pm – 4:10 pm
Table: There are no fools here. The clinical study presented by its author | co-author
Chairman:
President of the Brazilian Society of Mastology. Full Member of the Brazilian Academy of Mastology. Director of the Mastology Service of the CAM/Oncoclínicas Group. Salvador/BA 01/22/2024.
Speakers:
10’ Prospective study: Impact of breast magnetic resonance imaging on oncoplastic surgery and on indications of mastectomy in patients who were previously candidates to breast conserving surgery
Mastologist at the Breast Disease Center and the Mastology Center at Hospital Nossa Sra das Graças in Curitiba/PR. Master and PhD in Biotechnology.
Speakers:
10’ Outcomes after elevation of serratus anterior fascia flap versus serratus muscle flap in direct-to-implant breast reconstruction following mastectomy: a prospective study
Master and PhD's student in Health Sciences at the Federal University of Rio Grande do Sul. Mastologist at Hospital Aristides Maltez and CAM Grupo Oncoclínicas. Member of the Medical Residency Department of the Brazilian Society of Mastology (SBM) and Treasurer of SBM - Bahia Regional.
Speakers:
10’ Factors associated with unsatisfactory cosmetic results in oncoplastic surgery
Mastologist at Hospital de Amor Barretos. Post-doctorate at the Faculty of Medicine of Botucatu – UNESP. Professor of the Stricto Sensu Postgraduate Programs in Oncology and Health Innovation at Hospital de Amor. Member of the TEMa Commission. Coordinator of the SBM-SP Oncoplasty Committee.
Discussion
10’
4:10 pm – 4:40
Coffee Break
4:40 pm – 5:10 pm
Gold Satellite Symposium – ZEISS – The case for intraoperative radiotherapy: results and insights from the TARGIT a trial
Chairwoman:
Radio-Oncologist at the Cancer Hospital Araújo Jorge, the Institute of Mastology and Oncology - IMO and CEBROM Grupo Oncoclinicas of Goiânia. Master's and PhD from the Federal University of Goiás. Member of the current Board of Directors of the Brazilian Society of Radiotherapy.
Speaker:
Professor of Surgery. Division of Surgical Oncology. Director, Breast Surgery Oncology Fellowship.
5:15 pm – 5:45 pm
ASTRAZENECA – Mechanisms of endocrine resistance
Speaker:
Dr. Jahanzeb is the Co-Founder and President of OncAdvisor (a concierge oncology second opinion company) and co-founded PrecisCa (a virtual multidisciplinary and multi-institutional expert tumor panel for point-of-care second opinions). His most recent practice sites were Florida Cancer Specialists and Florida Precision Oncology. He was formerly a Professor of Clinical Medicine, Hematology/Oncology at University of Miami’s Miller School of Medicine, where he also served as the Associate Director of Community Outreach and Medical Director of the Deerfield Campus for the Sylvester Comprehensive Cancer Center for about nine years. He received his oncology training at Washington University/Barnes-Jewish Hospital in St. Louis, MO, where he subsequently served on Faculty. He has practiced and led clinical research in lung and breast cancer medical oncology for about 30 years.
5:50 pm – 6:30 pm
General session 4
Coordinator:
Oncologista clínico pelo INCA; Professor Adjunto de Medicina - UFPE. Mestre em Oncologia – USP; Doutor em Biologia Aplicada à Saúde pela UFPE; Pesquisador do Laboratório de Imunopatologia Keizo Asami - LIKA/UFPE e Coordenador do Centro de Pesquisa Clínica do Hospital das Clínicas da UFPE. Pós-graduada em Oncologia da Mama/Hosp Israelita Albert Einstein-SP.
Discussants:
Head doctor in the Department of Radiotherapy at Hospital Sírio-Libanês in São Paulo. Free Professor at the FMUSP Faculty of Medicine. President of the Brazilian Society of Radiotherapy.
PhD in Experimental Breast Pathology. Director of IMPED - Institute of Medicine Research and Development. Head of the Breast Service at Hospital Conceição.
5:50 pm – 6 pm
First interim analysis of radiotherapy data after 4.5 years of sentinel lymph node biopsy Versus no axillary surgery in early breast cancer clinically and UltraSonographically node negative: a prospective randomized controlled trial – VENUS Trial
6 pm – 6:10 pm
Patient-reported aesthetic outcomes in Oncoplastic Breast Surgery compared to Conventional Breast-Conserving Surgery: a systematic review and meta-analysis
6:10 pm – 6:20 pm
Breast conservation therapy or mastectomy and breast reconstruction in the treatment of locally advanced and/or Multifocal/Multicentric breast cancer? Systematic review and meta-analysis
6:20 pm – 6:30 pm
Discussion
